Biosenta Inc.
ZRO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.10% | -5.13% | -9.38% | 63.06% | 63.50% |
| Total Depreciation and Amortization | -15.79% | -40.74% | -22.73% | 5.88% | 58.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.62% | -5.92% | 18.07% | -69.54% | -72.28% |
| Change in Net Operating Assets | 63.36% | 123.89% | 121.71% | -8.67% | -14.95% |
| Cash from Operations | 20.33% | 28.56% | 43.26% | 52.55% | 36.16% |
| Capital Expenditure | 93.51% | 93.51% | -- | -59.48% | -59.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.51% | 93.51% | -- | -59.48% | -59.48% |
| Total Debt Issued | 69.78% | 67.96% | -- | 227.13% | -27.72% |
| Total Debt Repaid | 99.87% | 99.93% | 99.97% | 115.53% | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -51.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99.97% | -99.95% | -99.97% | -99.97% | 2,652.48% |
| Cash from Financing | -21.16% | -24.69% | -37.75% | -49.18% | -36.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 160.81% | 64.97% | 1,145.45% | 97.09% | -257.45% |